In the case of the Spinal Muscular Atrophy Registry, in addition to genetic validation (type of disease-causing variants/deletion, SMN2 copy number), it is important to confirm the type of SMA depending on the maximum motor level reached—without DMTs—and the age of onset of symptoms. This evidence concerns the gene SMN2 and spinal muscular atrophy.